Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Study of Acetyl-L-Carnitine (ALC) Hydrochloride Enteric-coated Tablets in Treatment of Peripheral Sensory Neuropathy in Anti-cancer Chemotherapeutics Induce

NCT01526564 is registered in ClinicalTrials.gov with Lee's Pharmaceutical Limited as lead sponsor.

NCT NCT01526564
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01526564 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Study of Acetyl-L-Carnitine (ALC) Hydrochloride Enteric-coated Tablets in Treatment of Peripheral Sensory Neuropathy in Anti-cancer Chemotherapeutics Induce
Lead sponsor
Lee's Pharmaceutical Limited
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2008
Completion date
July 31, 2011
Enrollment
239 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral sensory neuropathy